A Pediatric Cardiomyopathy Cohort Study: the Emerging Role of CMR in Clinical Practice
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pediatric Cardiomyopathy
- Sponsor
- West China Second University Hospital
- Enrollment
- 800
- Locations
- 1
- Primary Endpoint
- Major adverse cardiovascular events
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
This observational study aims to manage children with cardiomyopathy in the long term. It collects baseline data, laboratory test data, and medical imaging data during the hospitalization and follow-up.
During their disease progress, participants will undergo cardiovascular magnetic resonance, echocardiography, electrocardiography, laboratory tests, and when hospitalization and follow-up, and the baseline data will be collected in the admission. All the above examination data will be analysed to assess the clinical characteristics, current status of diagnosis and treatment, and the prognostic risk factors for children with cardiomyopathy.
Investigators
Ling-Yi Wen
Principal Investigator
West China Second University Hospital
Eligibility Criteria
Inclusion Criteria
- •Pediatric patients diagnosed with cardiomyopathy.
Exclusion Criteria
- •a history of cardiovascular disease ( such as congenital heart disease, cardiomyopathy, rheumatic heart disease, valvular disease ).
- •Mentally abnormal.
- •Poor compliance.
- •Heart, kidney and other important organs were seriously incomplete.
Outcomes
Primary Outcomes
Major adverse cardiovascular events
Time Frame: 10 years after the onset
Major adverse cardiovascular events including cardiac death, transient ischemic attack or stroke, myocardial infarction, arrhythmia, heart failure, severe valvular disease, percutaneous coronary intervention, coronary artery bypass graft, and other cardiovascular surgery.